Almost two-thirds of women in British Columbia filled at least one prescription at some point in their pregnancy, including drugs with potential risks, according to a new study by University of British Columbia researchers.
Almost two-thirds of women in British Columbia filled at least one prescription at some point in their pregnancy, including drugs with potential risks, according to a new study by University of British Columbia researchers.
Researchers from the University of British Columbia, Child & Family Research Institute (CFRI) and BC Children’s Hospital (BCCH) have won a $2.8-million grant from the Canadian International Development Agency (CIDA) to improve the survival rate of Bangladeshi mothers, newborns and young children through the prevention of sepsis, a life-threatening form of infection in which the bloodstream is overwhelmed by bacteria.
A clinical trial to test better treatment options for chronic heroin addiction is expected to begin in Vancouver at the end of this year. Led by researchers from Providence Health Care and the University of British Columbia, it’s the only clinical trial of its kind in North America.
Three research projects at the University of British Columbia have won five-year grants totaling nearly $6 million from the Canadian Institutes of Health Research (CIHR) to promote greater equity in global health.
A cell phone-sized, wireless near-infrared device is as reliable as the current “gold standard” invasive tests in determining bladder disease, according to a study by researchers at the University of British Columbia, Vancouver Coastal Health and the Child & Family Research Institute (CFRI).
Researchers from UBC’s Faculties of Medicine, Science and Dentistry are leading a $4.7 million pan-Canadian clinical trial aimed at improving outcomes for patients undergoing surgery for oral squamous cell cancers.
Two of Canada’s most eminent health researchers – Dr. Jacques Genest at McGill University and Dr. Michael Hayden at the University of British Columbia – have been awarded the inaugural Margolese National Brain and Heart Disorders Prizes, the most lucrative prizes bestowed by UBC.
Drospirenone, the top-selling oral contraceptive marketed as Yaz or Yasmin in the U.S. and Canada, doesn’t carry any more risk of gall bladder disease than the older generation of birth control pills, despite claims by some consumers and lawyers in both countries, according to a new study by University of British Columbia and Vancouver Coastal Health Research Institute researcher Mahyar Etminan.
The University of British Columbia today announced a $15 million gift from Vancouver philanthropist Djavad Mowafaghian for a new facility that integrates brain research and patient care. In honour of his generosity – the largest gift to date to the UBC Faculty of Medicine – the facility will be named the Djavad Mowafaghian Centre for Brain Health.
Dr. Michael Hayden has received the Canada Gairdner Wightman Award, the premier honour for leadership in medical science in Canada.